EDGAR Filing Documents for 0001654954-16-005079

Form 8-K/A - Current report: [Amend]

SEC Accession No. 0001654954-16-005079

Filing Date

2016-12-22

Accepted

2016-12-22 15:03:52

Documents

Period of Report

2016-12-14

Items

Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	PRIMARY DOCUMENT	mdit8ka_dec142016.htm	8-K/A	25335
2	INVESTOR PRESENTATION	ex99-1.htm	EX-99.1	39689
3	IMAGE	ex99-1000.jpg	GRAPHIC	21968
4	IMAGE	ex99-1001.jpg	GRAPHIC	60498
5	IMAGE	ex99-1002.jpg	GRAPHIC	26866
6	IMAGE	ex99-1003.jpg	GRAPHIC	33884
7	IMAGE	ex99-1004.jpg	GRAPHIC	35430
8	IMAGE	ex99-1005.jpg	GRAPHIC	24677
9	IMAGE	ex99-1006.jpg	GRAPHIC	25080
10	IMAGE	ex99-1007.jpg	GRAPHIC	28497
11	IMAGE	ex99-1008.jpg	GRAPHIC	32104
12	IMAGE	ex99-1009.jpg	GRAPHIC	31728
13	IMAGE	ex99-1010.jpg	GRAPHIC	28705
14	IMAGE	ex99-1011.jpg	GRAPHIC	24854
15	IMAGE	ex99-1012.jpg	GRAPHIC	34844
16	IMAGE	ex99-1013.jpg	GRAPHIC	34277
17	IMAGE	ex99-1014.jpg	GRAPHIC	38019
18	IMAGE	ex99-1015.jpg	GRAPHIC	25744
19	IMAGE	ex99-1016.jpg	GRAPHIC	28691
20	IMAGE	ex99-1017.jpg	GRAPHIC	23548
21	IMAGE	ex99-1018.jpg	GRAPHIC	27125
22	IMAGE	ex99-1019.jpg	GRAPHIC	26906
23	IMAGE	ex99-1020.jpg	GRAPHIC	27325
24	IMAGE	ex99-1021.jpg	GRAPHIC	28037
25	IMAGE	ex99-1022.jpg	GRAPHIC	29565
26	IMAGE	ex99-1023.jpg	GRAPHIC	17095
	Complete submission text file	0001654954-16-005079.txt		1054960

Mailing Address 414 NORTH ORLEANS STREET SUITE 502 CHICAGO IL 60610

Business Address 414 NORTH ORLEANS STREET SUITE 502 CHICAGO IL 60610 4078490290

Medite Cancer Diagnostics, Inc. (Filer) CIK: 0000075439 (see all company filings)